Suppr超能文献

[肉毒杆菌毒素的适应症及管理]

[Indications and management of botulinum toxin].

作者信息

Singer C

机构信息

Escuela de Medicina, Universidad de Miami, Florida, USA.

出版信息

Rev Neurol. 1999;29(2):157-62.

Abstract

INTRODUCTION

Botulinus toxin (BTX) is the most potent biological toxin yet known. It is produced by Clostridium botulinium, a Gram positive bacteria.

DEVELOPMENT

Type A Botulinus toxin is the most widely used in human drug trials. It has become the treatment of choice for blepharospasm, hemifacial spasm, cervical dystonia and laryngeal dystonia. It may also be used in the treatment of patients with oromandibular dystonia and limb dystonia, especially writer's cramp, and has been used successfully in the treatment of spasticity and cerebral paralysis. There are many benefits from this treatment, including improved walking, improved posture of wheelchair patients, improvement of patients with spasms and easier extension of their arms and knees. The toxin also alleviates pain and may be used in therapeutic trials for prediction of the response to surgical elongation.

摘要

引言

肉毒杆菌毒素(BTX)是目前已知的最具毒性的生物毒素。它由革兰氏阳性菌肉毒梭菌产生。

发展

A型肉毒杆菌毒素在人体药物试验中应用最为广泛。它已成为眼睑痉挛、半面痉挛、颈部肌张力障碍和喉部肌张力障碍的首选治疗方法。它也可用于治疗口下颌肌张力障碍和肢体肌张力障碍患者,尤其是书写痉挛,并且已成功用于治疗痉挛和脑瘫。这种治疗有许多益处,包括改善行走、改善轮椅患者的姿势、改善痉挛患者的状况以及使他们的手臂和膝盖更容易伸展。该毒素还可减轻疼痛,并可用于预测手术延长反应的治疗试验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验